UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Genetics of Pulmonary Arterial Hypertension

Circulation research, 2014-06, Vol.115 (1), p.189-202

2014

Volltextzugriff (PDF)

Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association

Circulation (New York, N.Y.), 2019-07, Vol.140 (1), p.e9-e68

2019

Volltextzugriff (PDF)

EIF2AK4 Mutations in Pulmonary Capillary Hemangiomatosis

Chest, 2014-02, Vol.145 (2), p.231-236

2014

Volltextzugriff (PDF)

KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models

International journal of molecular sciences, 2021-05, Vol.22 (9), p.5014

2021

Volltextzugriff (PDF)

Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension

PloS one, 2013-11, Vol.8 (11), p.e80319-e80319

2013

Volltextzugriff (PDF)

Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension

Respiratory research, 2009-09, Vol.10 (1), p.87-87, Article 87

2009

Volltextzugriff (PDF)

Developing a Broader Understanding of Pediatric PAH Worldwide

Chest, 2023-06, Vol.163 (6), p.1353-1355

2023

Volltextzugriff (PDF)

Pulmonary Hypertension in Children

Clinics in chest medicine, 2024-09, Vol.45 (3), p.685-693

2024

Volltextzugriff (PDF)

BMPR2 expression is suppressed by signaling through the estrogen receptor

Biology of sex differences, 2012-02, Vol.3 (1), p.6-6

2012

Volltextzugriff (PDF)

Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers

Cell stem cell, 2017-04, Vol.20 (4), p.490-504.e5

2017

Volltextzugriff (PDF)

Recent Advances in Pediatric Pulmonary Hypertension: Implications for Diagnosis and Treatment

Clinical therapeutics, 2023-09, Vol.45 (9), p.901-912

2023

Volltextzugriff (PDF)

Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension

Circulation (New York, N.Y.), 2016-05, Vol.133 (20), p.1936-1944

2016

Volltextzugriff (PDF)

Expression of a Human Caveolin-1 Mutation in Mice Drives Inflammatory and Metabolic Defect-Associated Pulmonary Arterial Hypertension

Frontiers in medicine, 2020-09, Vol.7, p.540-540

2020

Volltextzugriff (PDF)

COL18A1 genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association study

ERJ open research, 2022-04, Vol.8 (2), p.725

2022

Volltextzugriff (PDF)

Point Prevalence, Clinical Characteristics, and Treatment Variation for Infants with Severe Bronchopulmonary Dysplasia

American journal of perinatology, 2015-08, Vol.32 (10), p.960-967

2015

Volltextzugriff (PDF)

Exploring the Association of Male Sex With Adverse Outcomes in Severe Bronchopulmonary Dysplasia: A Retrospective, Multicenter Cohort Study

Chest, 2024-03, Vol.165 (3), p.610

2024

Volltextzugriff (PDF)

Genetics and mediators in pulmonary arterial hypertension

Clinics in chest medicine, 2007-03, Vol.28 (1), p.43-57

2007

Volltextzugriff (PDF)

Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension

Circulation. Cardiovascular genetics, 2012-06, Vol.5 (3), p.336-343

2012

Volltextzugriff (PDF)

ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical Worsening

Chest, 2021-07, Vol.160 (1), p.297-306

2021

Volltextzugriff (PDF)

Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II–Associated Pulmonary Arterial Hypertension Through MicroRNA-29–Mediated Modulation of Cellular Metabolism

Circulation (New York, N.Y.), 2016-01, Vol.133 (1), p.82-97

2016

Volltextzugriff (PDF)

Learning a Comorbidity-Driven Taxonomy of Pediatric Pulmonary Hypertension

Circulation research, 2017-08, Vol.121 (4), p.341-353

2017

Volltextzugriff (PDF)

Pulmonary hypertension in the premature infant: a challenging comorbidity in a vulnerable population

Current opinion in pediatrics, 2016-06, Vol.28 (3), p.324-330

2016

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

ThemaMiddle Aged

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(164)

Publikationsform

Sprache

Englisch
(199)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

The Genetics of Pulmonary Arterial Hypertension

Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association

2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT

EIF2AK4 Mutations in Pulmonary Capillary Hemangiomatosis

KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models

Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension

Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension

Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension

Developing a Broader Understanding of Pediatric PAH Worldwide

Pulmonary Hypertension in Children

BMPR2 expression is suppressed by signaling through the estrogen receptor

Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers

Recent Advances in Pediatric Pulmonary Hypertension: Implications for Diagnosis and Treatment

Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension

Expression of a Human Caveolin-1 Mutation in Mice Drives Inflammatory and Metabolic Defect-Associated Pulmonary Arterial Hypertension

COL18A1 genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association study

Point Prevalence, Clinical Characteristics, and Treatment Variation for Infants with Severe Bronchopulmonary Dysplasia

Exploring the Association of Male Sex With Adverse Outcomes in Severe Bronchopulmonary Dysplasia: A Retrospective, Multicenter Cohort Study

Genetics and mediators in pulmonary arterial hypertension

Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension

Multiple biomarkers are equivalent to clinical pulmonary arterial hypertension survival risk models

ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical Worsening

Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II–Associated Pulmonary Arterial Hypertension Through MicroRNA-29–Mediated Modulation of Cellular Metabolism

Learning a Comorbidity-Driven Taxonomy of Pediatric Pulmonary Hypertension

Pulmonary hypertension in the premature infant: a challenging comorbidity in a vulnerable population

Aktive Filter

Suchergebnisse filtern